Metraipolis › archive › dc_cb2931cc8f57

Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers — Europe PMC PMID:41848906

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41848906
DOI
10.1007/s10741-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-04T06:54:34.087Z
SHA-256 of the archived text
ffb71d6d8de55e58fead2b3243ca7be22c565e6b62ab5bae40abf27a71db1113
Stable URL of this page
https://metraipolis.com/documento/dc_cb2931cc8f57

How to cite

Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers — Europe PMC PMID:41848906 — Europe PMC (en), https://europepmc.org/article/MED/41848906 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb2931cc8f57 (Metraipolis archive dc_cb2931cc8f57, sha256 ffb71d6d8de55e58fead2b3243ca7be22c565e6b62ab5bae40abf27a71db1113)
BibTeX
@misc{dccb2931cc8f57,
  title = {Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers — Europe PMC PMID:41848906},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41848906},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb2931cc8f57; sha256 ffb71d6d8de55e58fead2b3243ca7be22c565e6b62ab5bae40abf27a71db1113},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41848906. Agents can read the archived copy with the MCP tool read_document.